Home / Inspections / 1028939

FDA Inspection 1028939 — Lonza Biologics, Inc.

Lonza Biologics, Inc. — FEI 3001451441

The FDA completed an inspection of Lonza Biologics, Inc. on September 21, 2017 in Portsmouth, NH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 21, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Portsmouth, NH (United States)

Facility

Other inspections at this facility

  • 1304046 (VAI Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1232144 (VAI Thu Mar 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1210690 (VAI Fri Jul 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988692 (VAI Fri Aug 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 914920 (VAI Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources